C12Y 301/03078
Phosphatidylinositol-4,5-bisphosphate 4-phosphatase
Official title: Phosphatidylinositol-4,5-bisphosphate 4-phosphatase (3.1.3.78)
C12Y301/03078 (Phosphatidylinositol-4,5-bisphosphate 4-phosphatase) appears on 0 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 0
- Published applications
- 3
- Assignees
- 1
- Inventors
- 3
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
By publication year.
Recent patents
No granted patents in this class yet.
- Pip2 as a marker for hdl function and cardiovascular disease risk2 Sep 2021US 2021/0270855 A1The Cleveland Clinic Foundation
- Pip2 as a marker for hdl function and cardiovascular disease risk2 Jul 2020US 2020/0209264 A1The Cleveland Clinic Foundation
- Pip2 as a marker for hdl function and cardiovascular disease risk23 Nov 2017US 2017/0336425 A1The Cleveland Clinic Foundation
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.